December 2009. Volume 5. Number 4

What is the evidence for using oseltamivir in influenza?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AT | Translated Articles

Translator: Aizpurua Galdeano P1.
1ABS 7 La Salut Badalona. Badalona. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Publication date: 01/01/2009

AT | Translated Articles

Translator: Aizpurua Galdeano P1.
1ABS 7 La Salut Badalona. Badalona. España.
Correspondence: Pilar Aizpurua Galdeano. Email: 19353pag@gmail.com
Publication date: 01/01/2009

Article Origin

Sitio web del Servicio de preguntas y respuestas clínicas: “TRIPanswers”. TRIP Database (TRIP Database Limited) Traducción autorizada.

Los autores del documento original no se hacen responsables de los posibles errores que hayan podido cometerse en la traducción del mismo.


Structured Abstract Authors

Equipo de ATTRACT (Servicio y repositorio de preguntas y respuestas clínicas del National Public Health Service for Wales).

Translated Article

Sorry, there is no English version for this item.

How to cite this article

Aizpurua Galdeano P. ¿Qué evidencia existe sobre el uso de oseltamivir para el tratamiento de la gripe? Evid Pediatr. 2009;5:89. Traducción autorizada de: TripAnswers. What is the evidence for using oseltamivir in influenza? TRIP Database Limited. Servicio y Repositorio de Preguntas y Respuestas Clínicas: “TripAnswers” (sitio web de TripAnswers). Documento número 6104 [en línea] [fecha de consulta: 23-10-2009]. Disponible en: http://www.tripanswers.org/answer.aspx?criteria=&tagtrail=%2F&qid=6104&src=0

References

  1. NICE. Amantadine, oseltamivir and zanamivir for the treatment of influenza. National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 168 (Review of NICE technology appraisal guidance 58). Feb 2009.
  2. NICE. Oseltamivir, amantadine and zanamivir for the prophylaxis of influenza. National Institute for Health and Clinical Excellence. NICE technology appraisal guidance 158 (including a review of NICE technology appraisal guidance 67). Sep 2008.
  3. NIHR Health Technology Assessment programme . Amantadine, oseltamivir and zanamivir for the prophylaxis of influenza (including a review of existing guidance no. 67): a systematic review and economic evaluation. HTA. February 2009.
  4. Jefferson T, Demicheli V, Di Pietrantonj C, Jones M, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD001265. DOI: 10.1002/14651858.CD001265.pub2.
  5. Matheson NJ, Harnden A, Perera R, Sheikh A, Symmonds-Abrahams M. Neuraminidase inhibitors for preventing and treating influenza in children. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD002744. DOI: 10.1002/14651858.CD002744.pub2.

Document Type


01/01/2009

Linked Comment